Key Metrics
7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.4
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Neuroendocrine tumors
- Doxorubicin
- Immunotherapy
- Surgical resection
- Breast cancer
- Overall survival
- Prime time
- Cardiotoxicity
- Proton therapy
- Osteosarcoma
- Prostate cancer
- Mycosis fungoides
- Cardiac metabolism
- Observational study
- Immune checkpoint inhibitors
- Triple-negative breast cancer
- Oncology
- Toxicity
- Doxorubicin cardiotoxicity
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Current Treatment Options in Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation
- 22 Mar 24
- Current Treatment Options in Oncology
-
Full paper
Ovarian Suppression: Early Menopause and Late Effects
- 13 Mar 24
- Current Treatment Options in Oncology
-
Full paper
Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma
- 13 Mar 24
- Current Treatment Options in Oncology
-
Full paper
Antiepileptic Strategies for Patients with Primary and Metastatic Brain Tumors
- 14 Feb 24
- Current Treatment Options in Oncology
-
Full paper
Research Progress on the Use of Metformin in Leukemia Treatment
- 30 Jan 24
- Current Treatment Options in Oncology
-
Full paper
Hypnosis for Symptom Management in Adult Cancer Patients: What is the Evidence?
- 4 Jan 24
- Current Treatment Options in Oncology
Scite analysis
Powered by scite_
1.5k articles received 24.6k citations see all
- 390 Supporting
- 23,285 Mentioning
- 55 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 14 Corrections
- 19 Errata
- 0 Expression of Concern
FAQs
How long has Current Treatment Options in Oncology been actively publishing?
Current Treatment Options in Oncology has been in operation since 1999 till date.
What is the publishing frequency of Current Treatment Options in Oncology ?
Current Treatment Options in Oncology published with a Monthly frequency.
How many articles did Current Treatment Options in Oncology publish last years ?
In 2023, Current Treatment Options in Oncology published 35 articles.
What is the eISSN & pISSN for Current Treatment Options in Oncology ?
For Current Treatment Options in Oncology,eISSN is 1534-6277 and pISSN is1527-2729.
What is Citescore for Current Treatment Options in Oncology ?
Citescore for Current Treatment Options in Oncology is 7.
What is SNIP score for Current Treatment Options in Oncology ?
SNIP score for Current Treatment Options in Oncology is 1.4.
What is the SJR for Current Treatment Options in Oncology ?
SJR for Current Treatment Options in Oncology is Q1.
Who is the publisher of Current Treatment Options in Oncology ?
SPRINGER is the publisher of Current Treatment Options in Oncology.